Starpharma Holdings Limited (SPHRF)
OTCMKTS · Delayed Price · Currency is USD
0.0982
+0.0142 (16.90%)
At close: Aug 26, 2025
Starpharma Holdings Market Cap
Starpharma Holdings has a market cap or net worth of $34.62 million as of September 10, 2025. Its market cap has increased by 30.45% in one year.
Market Cap
34.62M
Enterprise Value
26.01M
Revenue
3.84M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.10
Market Cap Chart
Since September 28, 2000, Starpharma Holdings's market cap has increased from 27.45M to 34.62M, an increase of 26.13%. That is a compound annual growth rate of 0.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2025 | 34.44M | 20.99% |
| Dec 31, 2024 | 28.46M | -40.36% |
| Dec 29, 2023 | 47.72M | -68.78% |
| Dec 30, 2022 | 152.84M | -61.43% |
| Dec 31, 2021 | 396.24M | -19.17% |
| Dec 31, 2020 | 490.21M | 54.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 823.67M |
| Elite Pharmaceuticals | 739.37M |
| Tian'an Technology Group | 675.94M |
| Glass House Brands | 596.87M |
| CytoDyn | 424.27M |
| Northwest Biotherapeutics | 378.39M |
| American Oncology Network | 353.52M |